Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00585806 · ClinicalTrials.gov registry record

Assessment of Cardiac Functional Reserve in Heart Failure With Preserved Ejection Fraction (HF-PEF)

A clinical trial of Heart Failure, sponsored by University of Wisconsin, Madison.

Completed
Registry status
19
Enrollment target
1
Study location

NCT00585806: Completed study of Heart Failure, sponsored by University of Wisconsin, Madison.

NCT00585806 is a study of Heart Failure that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 19 participants, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00585806, a study of Heart Failure, has completed, sponsored by University of Wisconsin, Madison.

COMPLETED
Registry status
19 participants
Enrollment target
1
Study location

Study Summary

This study will compare the ability of the heart to increase its contractile performance during stress in patients with a history of heart failure without systolic dysfunction and in controls.

Conditions Studied

Study Locations (1)

Wisconsin

  • University of Wisconsin Hospital and Clinics - Madison

Trial Details

FieldValue
Enrollment Target 19 participants
Start Date 2005-12
Est. Completion 2009-06
University of Wisconsin, Madison

1,039 total trials

What the finished NCT00585806 record still lists

NCT00585806 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 19 participants, a relatively small participant target, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (99% lower).

The record links to 1 condition, with Heart Failure appearing as the primary indexed condition, and to 0 interventions.

NCT00585806 reports a single indexed study location in Wisconsin.

Frequently Asked Questions

What is clinical trial NCT00585806 about?

NCT00585806 is a clinical study titled "Assessment of Cardiac Functional Reserve in Heart Failure With Preserved Ejection Fraction (HF-PEF)". This study will compare the ability of the heart to increase its contractile performance during stress in patients with a history of heart failure without systolic dysfunction and in controls.

What is the current status of trial NCT00585806?

This trial is currently completed. The enrollment target is 19 participants. The study started on 2005-12. Estimated completion is 2009-06.

What conditions does trial NCT00585806 study?

This clinical trial studies the following conditions: Heart Failure.

Who is sponsoring clinical trial NCT00585806?

This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00585806 being conducted?

This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Heart Failure

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00585806's enrollment target sits among peer trials

19 362nd of 397 higher than 34 of 397 other Heart Failure trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Heart Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03207464 · 19 participants · Phase 1

    Molecular Imaging of NET Using [C-11]MRB-PET in MS

  • NCT04318717 · 19 participants · Phase 2

    Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma

  • NCT05103904 · 19 participants · Phase 2

    Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant

  • NCT05607407 · 19 participants · Phase 2

    Methimazole in Patients With Progressive Glioblastoma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00585806, the US trial registry maintained by the National Library of Medicine. NCT00585806 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.